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Pluripotency and X chromosome dynamics
revealed in pig pre-gastrulating embryos by single
cell analysis
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High-resolution molecular programmes delineating the cellular foundations of mammalian
embryogenesis have emerged recently. Similar analysis of human embryos is limited to pre-
implantation stages, since early post-implantation embryos are largely inaccessible. Not-
withstanding, we previously suggested conserved principles of pig and human early devel-
opment. For further insight on pluripotent states and lineage delineation, we analysed pig
embryos at single cell resolution. Here we show progressive segregation of inner cell mass
and trophectoderm in early blastocysts, and of epiblast and hypoblast in late blastocysts. We
show that following an emergent short naive pluripotent signature in early embryos, there is a
protracted appearance of a primed signature in advanced embryonic stages. Dosage com-
pensation with respect to the X-chromosome in females is attained via X-inactivation in late
epiblasts. Detailed human-pig comparison is a basis towards comprehending early human
development and a foundation for further studies of human pluripotent stem cell differ-
entiation in pig interspecies chimeras.
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Pre-gastrulation embryo development shows broad simila-rities between mammals, although species-speciﬁc differ-ences in early lineage segregation, the establishment of
pluripotency, and X-chromosome inactivation have been repor-
ted1–3. Mouse embryos, which are widely used as a model for
mammals, transit rapidly through this early development phase
(E0-E5.5) that culminates with the formation of the characteristic
cup-shaped post-implantation epiblast. In larger mammals,
including humans, non-human primates (NHP) and pigs, there is
a protracted developmental period (~10–12 days) that ends with
the formation of a ﬂat bilaminar embryonic disc. Since early post-
implantation human embryos are largely inaccessible, and cur-
rently can only be studied with novel in vitro systems4,5, we are
beginning to investigate relatively more accessible pig embryos.
Notably both human and pig embryos evidently form a ﬂat
embryonic disc before the onset of gastrulation6. Thus, the pig
embryo can broaden our understanding of the pre-gastrulation
development of large mammals with protracted development.
Segregation of trophectoderm (TE) and hypoblast, and the
emergence of pluripotency are well established in mice, but
require detailed studies in other mammals at the resolution of
single cells, as recently reported for Cynomolgus monkeys2.
Potential discrepancies in lineage segregation have however
emerged in reports between monkey and human, attributed in
part to embryo staging differences7. Further studies, including
those in other large mammalian species, are therefore highly
desirable.
In mouse embryos a distinct transcriptional signature of
pluripotency in the inner cell mass (ICM) undergoes changes as
the epiblast (EPI) matures and develops further marking a tran-
sition through pluripotency before gastrulation8. These transitory
stages can be recapitulated in vitro in naive pluripotent stem cells
(PSCs), which resemble pre-implantation epiblast cells, and
primed PSCs resembling the post-implantation mouse epiblast9.
Establishment of similar cell lines from non-rodent mammalian
species, including humans, has been challenging, suggesting
possible biological differences10. Indeed, spatiotemporal differ-
ences in the expression of core pluripotency genes NANOG,
OCT4 (POU5F1) and SOX2 have been noted, while the expression
of Klf2, Prdm14 and Bmp4, observed in mouse embryonic naive
cells, are apparently not detectable in human embryos10,11. By
contrast, KLF17 is expressed in the human but not mouse ICM10–
12. Also, while members of the Jak-Stat3 and WNT signalling
pathways are detected in the early mouse ICM13, many TGFβ
signalling components are found in marmoset, human and pig
ICM11–14, indicating that the emergence and establishment of
pluripotency in mammals is controlled by different signalling
pathways and gene networks. Differences in the mechanisms of
X-linked gene dosage compensation in female embryos are also
evident3. The gene dosage compensation with respect to the X
chromosomes in female embryos occurs in pre-gastrulation epi-
blasts in mouse and rabbits3,8,15. Notably, human post-
implantation and pig pre-gastrulation epiblasts have not been
studied12,15.
Here we report lineage segregation, the establishment of plur-
ipotency, and X-chromosome inactivation during the entire peri-
gastrulation period in the pig embryo using single-cell RNA-seq
(scRNA-seq). This comprehensive analysis provides new under-
standing of the developmental trajectories of early embryonic cells
in the pig, which shares similarities with early human develop-
ment, and other mammals with similar embryology.
Results
Progressive lineage segregation in pig embryos. First, we set out
to generate a single-cell transcriptome proﬁle of early in vivo pig
embryo development, from four pre-implantation stages: morula
(M; embryonic day (E) ~4–5), early blastocyst (EB, ~E5–6), late
blastocyst (LB, ~E7–8), and spherical embryo (Sph, ~E10–11)16
(Fig. 1a), and obtained 220 single-cell transcriptomes from 28
embryos (Table 1, Source data ﬁle). Unsupervised hierarchical
clustering (UHC) (15,086 genes) grouped the cells according to
their developmental stage and speciﬁc lineages based on known
markers (Fig. 1b).
Dimensionality reduction provided a clear visualisation of
lineage segregation during development (Fig. 1c). The morula
group showed expression of OCT4 (POU5F1), SOX2, and KLF4,
but not NANOG, while early blastocyst (EB) cells segregated into
two lineages: ICM cells expressing NANOG and SOX2, and TE
cells with GATA2, GATA3 and DAB2. Expression of CDX2 was
seen in a few TE cells at this early stage14, but OCT4 expression
was seen in all cells, consistent with observations in human and
monkey blastocysts2,17. There was evident expression of plur-
ipotency genes; SOX15, KLF4 and KLF17 in the ICM and EPI, as
in human epiblast cells. Expression of some of these genes was
also seen in pig TE and hypoblast (HYPO).
We identiﬁed 708 differentially expressed genes (DEG)
between ICM and TE (Fig. 2a and Source data ﬁle). While
GATA2 and GATA3 were the two top-ranked genes in TE of early
blastocysts, other TE markers reported in mouse and human such
as ANXA6 and TEAD1 were identiﬁed for the ﬁrst time in the pig.
Notably, we found upregulation of both HYPO and EPI markers
in the ICM (Fig. 2b). Further interrogation of ICM cells by
principal component analysis (PCA) of all genes and highly
variable genes (Fig. 2c and d, respectively) did not separate the
cells into discrete populations. Analysis of highly variable genes
(HVGs) in a subset of cells separated along PC1 did not show a
distinct EPI or HYPO expression signature based on high-
conﬁdence markers7 (Fig. 2e). Mutually exclusive segregation of
EPI and HYPO became evident ﬁrst in cells of LB and Sph
embryos (TE was excluded from these stages) (Fig. 2c, d).
Expression of SOX2, NANOG, PRDM14 and NODAL was
observed in EPI, whereas expression of PDGFRα, GATA4,
GATA6, COL4A1, NID2 and HNF1β was detected in HYPO
(Fig. 1c). Comparison between EPI and HYPO in LB and Sph
identiﬁed 1810 and 1916 DEGs, respectively. Known EPI genes
upregulated in both stages included SOX15, ZIC3, FGF19, SALL2
and the HYPO genes PITX2, PECAM1, DAB2 and FN1 (Fig. 2a, b,
and Source data ﬁle). These results show that TE and ICM in the
pig embryo segregate in the early blastocyst, whereas at this stage,
HYPO and EPI genes are co-expressed in the ICM; these cells
resolve into discrete cell lineages in late blastocysts.
Signalling pathways controlling lineage segregation. Gene
ontology (GO) enrichment and Kyoto Encyclopaedia of Genes
and Genomes (KEGG) pathway analyses indicated that PI3K-Akt
and Jak-Stat signalling pathways were over-represented in ICM
and TE of early blastocysts (EB), but the WNT signalling pathway
was enriched only in ICM cells. In later stages, PI3K-Akt was
over-represented in HYPO and MAPK signalling in EPI. Com-
ponents of the TGFβ pathways were expressed in both EPI and
HYPO (Table 2 and Source data ﬁle).
For elucidating functional roles of these signalling pathways
during lineage segregation, we cultured ex vivo pig embryos at
different stages based on the gene expression proﬁle of the
signalling pathways under investigation (Fig. 3a). We used
selective inhibitors and determined the impact on lineage
allocation by assessing the number of NANOG and SOX17 cells
using immunoﬂuorescence (IF). In controls, NANOG was absent
in morulae, but detectable in most ICM cells from EB, which were
also positive for SOX2 (Fig. 3b, c). Expression of SOX17 was ﬁrst
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Fig. 1 Lineage segregation in pig pre-implantation embryos. a Pig pre-implantation embryos collected for scRNA-Seq. b Unsupervised hierarchical
clustering (UHC) with all expressed genes (15,086 genes), with a heat map of expression levels of lineage-speciﬁc markers. Colours in dendrogram
indicate developmental stage. c t-SNE plot of all cells, indicated by colours and shapes for different embryonic days and lineages. Lineage-speciﬁc genes are
shown in t-SNE plots; a gradient from white to red indicates low to high expression. n= 220 cells. E: embryonic day, M: morula, EB: early blastocyst, LB: late
blastocyst, Sph: spherical embryo, EPI: epiblast, HYPO: hypoblast, ICM: inner cell mass, TE: trophectoderm. Scale bar: 300 µm
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observed in a subset of NANOG positive (NANOG+) cells
(47.14%) in the ICM of EB, which became gradually restricted to
a small group of cells in the ICM of mid-blastocysts (MB, ~E6–7,
16.78%). By the late blastocyst (LB) stage (~E7–8), two mutually
exclusive groups of NANOG+ and SOX17+ cells were identiﬁed
(Fig. 3b, c).
Having established the sequence of NANOG and SOX17
expression, we ﬁrst looked at Jak-Stat signalling, since it was
highly represented in all cells of the EB (Table 2). In mouse, ICM
cells express LIF receptor (LIFR)18 and glycoprotein 130 (also
known as IL6ST), which bind LIF secreted by the neighbouring
TE19. In the pig, however, LIF expression was not detected
(Fig. 3d). Instead, IL6 was expressed in M and EB TE cells.
Similarly, high expression of IL6ST and IL6R was detected in ICM
and TE cells of EB, which decreased in LB and Sph EPI (Fig. 3d).
The effect of this growth factor during embryo development was
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Fig. 2 Differential gene expression in cells of the early pig embryo. a Numbers of differentially expressed genes (DEGs) during lineage segregation in
pairwise comparisons for each stage. Red and green bars indicate upregulated and downregulated genes, respectively. b Scatter-plot comparisons of the
averaged gene expression levels between different lineages (>1 fold change, ﬂanking diagonal lines; Yellow: upregulated, blue: downregulated; log10 (TPM
geometric means), key genes are annotated). c PCAs of EB ICM (n= 24 cells) and LB and Sph EPI and HYPO of all expressed genes (n= 121 cells). d PCA
of EB ICM (n= 24 cells) and LB and Sph EPI and HYPO cells by highly variable genes (HVG) (n= 121 cells). e Heat map of expression levels of epiblast-
and hypoblast-speciﬁc markers and HVG in seven selected EB ICM samples from c and d. M: morula, EB: early blastocyst, LB: late blastocyst, Sph: spherical
embryo, EPI: epiblast, HYPO: hypoblast, ICM: inner cell mass, TE: trophectoderm
Table 1 Samples of embryos collected
Stage No. of embryos No. of cells collected No. of cells sequenced Samples retained after quality control
Morula (~E4–5) 8 91 58 47
Early blastocyst (~E5–6) 10 158 57 52
Late blastocyst (~E7–8) 6 103 70 61
Spherical embryo (~E10–11) 4 113 65 60
Total 28 465 250 220
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tested by IL-6 supplementation to ex vivo-derived morulae. IL-6
supplemented embryos showed a modest increase in total cell
number, with the proportion of NANOG and SOX17 cells
unaffected (Fig. 3f). To further understand the role of IL6 during
blastocyst formation we disrupted the IL6 gene using CRISPR/
Cas9 gene editing in pig parthenogenetic embryos and cultured
these until the blastocyst stage. IL6 KO (homozygous and mosaic
embryos) had signiﬁcantly reduced numbers of TE cells
compared to sham injected embryos, however the ICM of these
embryos was unaffected (Fig. 3g; Supplementary Figure 2). We
also blocked Jak-Stat signalling in ex vivo embryos using a speciﬁc
inhibitor (AZD1480) and found that early blastocysts had a
signiﬁcantly reduced total cell number and no clear ICM (Fig. 3f).
While a small number of scattered SOX2+ cells were observed,
they were however not organised into an ICM, unlike in control
embryos (Fig. 3b). Embryos treated until the MB and LB stages
also had reduced total cell numbers, as a result of a reduction of
both the TE and ICM (Fig. 3e, f).
We also looked at the role of the PI3K-Akt signalling pathway
previously identiﬁed in mouse pre-implantation embryos20, since
we found it enriched in pig EB KEGG terms. Embryos treated
with the PI3K inhibitor LY294002 from PM to EB and from M to
MB developed small blastocysts with reduced numbers of
NANOG+ cells compared to controls (3 cells in LY294002 vs.
10 cells in controls) (Fig. 3e, f). The total cell number was also
reduced by more than 35 cells per embryo (Fig. 3f).
Next, we investigated the Activin/TGFβ pathway, which was
previously shown to be active during EPI development in human
and pig11,21,22. Supplementation of TGFβ1 at the morula stage
did not affect the total cell number nor the proportion of
NANOG and SOX17-positive cells in these embryos (Fig. 3f). We
next blocked the Activin/TGFβ pathway using SB431542 (20 or
40 µM) from PM to EB and M to MB and found no effect in
embryo development. In contrast, embryos treated from MB to
LB showed a signiﬁcant reduction in NANOG+ cells, but the
number of cells expressing SOX17 was unaffected (Fig. 3e, f).
These results indicate that TGFβ promotes the expansion of the
pluripotent epiblast in the pig embryo without affecting lineage
segregation, consistent with the ﬁndings in human embryos11.
In human, pig and cattle, inhibition of FGF signalling with a
MAPK/ERK kinase inhibitor (PD0325901; 0.4–1 µM) does not
abolish the expression of hypoblast markers23–25, in contrast to
mouse and rabbit embryos where it prevents hypoblast forma-
tion26,27. As our scRNA-Seq data show expression of MAPK
pathway genes in LB EPI cells, we tested the effect of the MEK
inhibitor PD0325901 at high concentration (10 µM), based on
previous results with cattle blastocysts28. MEK inhibition from M
to MB signiﬁcantly reduced the number of HYPO cells resulting
in <3 SOX17+ cells/embryo, with an apparent shift towards
NANOG+ cells in the ICM (Fig. 3e, f). This indicates that MAPK
inhibition restricts the expansion of the pig HYPO, but it does not
prevent the activation of SOX17 in some cells.
Table 2 Gene ontology terms and KEGG pathways determined by pairwise comparisons of embryonic lineages
Lineage GO terms KEGG pathways
EB ICM vs. EB TE
EB ICM Endodermal cell fate speciﬁcation (7.07e−04)
IL-6-mediated signalling pathway (1.05e−03)
Positive regulation of canonical Wnt sig. path. (1.28e−03)
Positive regulation of JAK-STAT cascade (2.37e−03)
Stem cell population maintenance (4.00e−03)
Signalling pathways regulating pluripotency of stem cells
(2.43e−06)
Calcium signalling pathway (8.48e−06)
Cell adhesion molecules (CAMs) (3.53e−04)
PI3K-Akt signalling pathway (5.57e−04)
EB TE Regulation of establishment of cell polarity (5.00e−04)
Positive regulation of cell migration (7.13e−04)
Cell proliferation (2.01e−03)
Positive regulation of cell proliferation (3.71e−03)
Positive regulation of JNK cascade (4.11e−03)
PI3K-Akt signalling pathway (1.23e−02)
Phagosome (1.31e−02)
Jak-STAT signalling pathway (3.17e−02)
Lysosome (4.56e−02)
Cell cycle (8.03e−02)
LB EPI vs. LB HYPO
LB EPI Negative regulation of transcription from RNA polymerase II promoter
(3.92e−05)
Histone H4-K5 and H4-K8 acetylation (1.69e−03)
Regulation of DNA methylation (1.10e−02)
C-5 methylation of cytosine (2.50e−02)
Chromatin silencing (4.13e−02)
MAPK signalling pathway (5.21e−03)
Neuroactive ligand-receptor interaction (2.55e−02)
Signalling pathways regulating pluripotency of stem cells
(3.20e−02)
ErbB signalling pathway (3.66e−02)
Adherens junction (3.75e−02)
LB HYPO Transmembrane transport (4.11e−05)
Response to glucose (1.35e−04)
Cholesterol efﬂux (1.63e−04)
Endodermal cell differentiation (1.81e−03)
Triglyceride homoeostasis (2.12e−03)
PI3K-Akt signalling pathway (4.87e−06)
ECM–receptor interaction (6.09e−06)
Cell adhesion molecules (CAMs) (5.98e−05)
Focal adhesion (2.16e−04)
PPAR signalling pathway (3.87e−04)
Sph EPI vs. Sph HYPO
Sph EPI Axon guidance (1.03e−04)
Regulation of neuron projection development (1.99e−04)
Glycogen catabolic process (3.50e−03)
Embryo implantation (7.88e−03)
Regulation of stem cell division (1.17e−02)
Stem cell population maintenance (1.25e−02)
PPAR signalling pathway (3.72e−22)
HIF-1 signalling pathway (1.54e−11)
Tight junction (3.69e−07)
Signalling pathways regulating pluripotency of stem cells
(6.67e−07)
Sph HYPO Endodermal cell differentiation (8.04e−05)
Endoderm development (1.74e−04)
Lipid transport (2.54e−04)
Response to glucose (2.84e−04)
Cell fate commitment (5.31e−04)
ECM–receptor interaction (1.20e−04)
TGF-beta signalling pathway (1.77e−04)
Cytokine–cytokine receptor interaction (1.18e−03)
PPAR signalling pathway (2.81e−03)
Cell adhesion molecules (CAMs) (3.93e−03)
Signiﬁcance values in brackets
M morula, EB early blastocyst, LB late blastocyst, Sph spherical embryo, ICM inner cell mass, TE trophectoderm, EPI epiblast
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Lastly, since regulation of the canonical WNT pathway was a
signiﬁcantly upregulated GO term in the ICM, we cultured pig
embryos with the tested WNT inhibitor IWP2. No reduction in
hypoblast segregation nor the total cell number was observed
following WNT inhibition from M to MB (Fig. 3e, f); similar
observations were reported for mouse embryos13.
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Emergence and progression of pluripotency in the pig embryo.
We next sought to determine how the emergent pluripotent cells
(ICM) of EB compared to early (LB) and late EPI (Sph) (Table 3).
In a three-dimensional PCA plot, cells grouped as two main
clusters: M/ICM and LB/Sph EPI cells (Fig. 4a). We detected a
biphasic proﬁle of pluripotent gene expression, with high
expression of naive pluripotency genes in M/ICM, and gradual
downregulation of these markers in EPI cells (LB/Sph). Con-
comitantly with the decrease in naive markers, there was an
upregulation of primed pluripotency genes in LB/Sph EPI
(Fig. 4b). Essential differences in gene expression were noted in
the pig compared to observations in the mouse29; while OCT4
and SOX2 expression were maintained along all pluripotent
stages, expression of NANOG was ﬁrst observed in the ICM and
remained high in LB and Sph EPI. The naive pluripotency mar-
kers KLF4, KLF5, KLF17, TFCP2L1, ESRRB and TBX3, were
detected in M and ICM and decreased, or even ceased in LB and
Sph EPI. The exception was PRDM14, which followed the
opposite trend. By contrast, primed pluripotency markers
NODAL, DNMT3B, SALL2 and SFRP2 were upregulated in LB
and Sph EPI. Continued expression of pluripotency markers and
absence of lineage commitment gene expression (MIXL1, FOXA2,
and T) in Sph EPI indicated a protracted exit from pluripotency
(about 6 days) in the pig.
We used K-means clustering to group genes with similar
expression proﬁles (Fig. 4c). Genes highly expressed in morulae
and ICM cells (cluster 5, 15, 20, 24, 25) include naive
pluripotency markers, members of the Jak-Stat pathway, TET2,
and components of the Polycomb Repressive Complex 2 (PRC2)
EZH2 and EED. Genes upregulated in LB and Sph EPI (cluster 6,
11, 16, 22) include primed pluripotency markers, DNA
methyltransferases, genes indicative of glycolytic metabolism
and TGFβ signalling. The transition from naive to primed
pluripotent gene expression was further evidenced by the 3138
DEGs between ICM and Sph EPI (Fig. 5a, b, Source data ﬁle). GO
enrichment and KEGG pathways analyses between these stages
showed that PI3K-Akt, Jak-Stat and Interleukin-6-mediated
signalling pathways were upregulated in ICM cells (Table 4,
Fig. 5b, c).
Interestingly, no signiﬁcant changes in signalling pathways
affecting pluripotency were observed between early (LB) and late
(Sph) EPI, indicating that the primed EPI stably maintains its
properties over ~6 days (Table 4, Fig. 5d).
Novel surface speciﬁc markers in pig pluripotent cells. We
sought to identify novel pluripotency markers in the pig, by
comparing our scRNA-Seq dataset with the cell surface protein
atlas30. Surface markers described in human naive and primed
pluripotent cells31, such as CD130 (IL6ST) and CD24, were not
lineage-speciﬁc in the pig embryo (Fig. 6a). Instead, we found
CD247 primarily marking the ICM and LB EPI, while CD90
(THY1) was detected in LB and Sph EPI (Fig. 6a). Notably,
CD200, CD79B and CD83 were speciﬁcally expressed in late
epiblast cells and could constitute primed pluripotency cell sur-
face markers in the pig. Candidates for new naive markers were
CD200R1, expressed only in M and ICM cells, and CD244,
expressed exclusively in ICM. We conﬁrmed the expression of
CD244 by IF, which unexpectedly showed nuclear localisation
within a subpopulation of SOX2+ cells in the ICM of EB. A small
number of cells also showed SOX17 co-expression, suggesting
that cells segregating towards hypoblast gradually lose CD244
protein. By the MB stage, CD244 was almost undetectable, con-
sistent with scRNA-seq data showing downregulation of this
marker in late blastocysts (Fig. 6b).
Distinct metabolic and epigenetic landscapes of pluripotency.
A shift towards glycolytic metabolism and reduced mitochondrial
activity is associated with the development from naive to primed
pluripotency in mouse and human PSC32,33; this metabolic
switch has also been described in the mouse epiblast33. DEG and
GO term analysis between ICM and Sph EPI cells suggested a
metabolic switch during this period in the pig embryo (Table 4).
Notably, ESRRB and STAT3, which stimulate oxidative phos-
phorylation (OXPHOS) during maintenance of naive plur-
ipotency34, were upregulated in M and ICM, but were later
downregulated in LB and Sph EPI. Enzymes involved in the tri-
carboxylic acid (TCA) cycle and OXPHOS, such as IDH1, ACO2
and UQCRC2 followed the same trend, as well as EGLN1, which
prevents HIF-1α stabilisation and is downregulated in primed
pluripotent cells35 (Fig. 7a; Supplementary Figure 3). LIN28A and
LIN28B maintain low mitochondrial function in primed plur-
ipotent cells32,36, and MYC binds to the LIN28B locus and
potentiates glycolysis37. These genes were upregulated in pig EPI.
A similar expression pattern was noted for HIF-1α, a hypoxia-
inducible factor upregulated during the transition from naive to
primed state33, concomitantly with the upregulation of down-
stream enzymes HK1, GBE1, PGM1 and PYGL, required to
convert glucose to glycogen. Finally, the glycolytic enzymes
Fig. 3 Signalling pathways involved in segregation of lineages. a Experimental design of embryo treatments. b Bright ﬁeld and IF staining for indicated
markers; embryos were counterstained with DAPI (merge). Scatter dot plots of NANOG-, SOX17-positive cells and total cell numbers (black bar indicates
mean) of control pig morula (M, n= 7), early blastocysts (EB, n= 8), mid-blastocysts (MB, n= 9) and late blastocysts (LB, n= 5). c Bar charts indicating
percentage of ICM cells expressing indicated markers in control embryos. d Gene expression of LIF/IL6 and its cognate receptors in pig embryos. e Bar
charts indicating percentage of ICM cells expressing indicated markers after different treatments. f Scatter plots show proportion of cells stained for the
indicated markers in control embryos (EB n= 8, MB n= 9, LB n= 5) and embryos treated with JAKi: 10 µM AZD1480 (EB n= 11, MB n= 4, LB n= 8),
PI3Ki: 10 µM LY294002 (EB n= 7, MB n= 5), TGFβi: 20 µM SB431542 (EB n= 3, MB n= 7, LB n= 7), MEKi: 10 µM PD0325901 (MB n= 7), WNTi: 3 µM
IWP2 (MB n= 9), IL6: 10 ngml−1 (MB n= 8) and TGFβ: 10 ng ml−1 (MB n= 8). g Scatter plots show the number of cells stained in Sham controls (n=
24), homozygous KO (IL6−/−) (n= 9) and mosaic embryos (n= 6) after CRISPR/Cas9 gene editing. ICM cells were determined by counting SOX2
positive cells and TE cells were calculated by subtracting SOX2 cells from the total cell count. Ctr: control, PM: pre-morula. For c, e: *p≤ 0.05, two-way
ANOVA. For f, g: *p≤ 0.05, Mann–Whitney test. Source data are provided as a Source Data ﬁle. Scale bars: 50 µm
Table 3 Summary of female and male cells analysed
Stage Cells Embryos
Male Female Male Female
M 32 15 5 3
EB ICM 18 6 4 6
EB TE 8 20
LB EPI 13 12 3 3
LB HYPO 4 32
Sph EPI 37 11 3 1
Sph HYPO 12 0
Total 124 96 15 13
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LDHA33,38 and metabolite transporter UCP2, which limit pyr-
uvate oxidation and facilitate glycolysis, were also upregulated in
EPI cells (Fig. 7a; Supplementary Figure 3). We also detected a
reduction in expression of electron transfer complex IV (cyto-
chrome c oxidase) genes (11/20 genes) during the maturation of
the epiblast (Fig. 7b), suggesting a reduction in mitochondrial
metabolism33.
We observed downregulation of the fatty acid transporter to
the mitochondria CPT1A and a concomitant increase of critical
fatty acid synthesis genes SLC25A1 and ACLY in EPI cells
compared to ICM; this is in agreement with previous reports
indicating accumulation of long-carbon-chain lipids during the
conversion from naive to primed pluripotency in mouse and
human35 (Fig. 7a).
Epigenetic modiﬁcations are highly responsive to metabolites
derived from pathways such as the TCA cycle or glycolysis, in
particular, DNA methyltransferases (DNMT), histone acetyl-
transferases and histone methyltransferases39. GO terms related
to de novo DNA methylation were upregulated in EPI cells
(Fig. 5c, Table 4). Accordingly, the expression of DNMT3A,
DNMT3B and HELLS, required for de novo DNA methylation40,
signiﬁcantly increased in LB and Sph EPI. Concomitantly, TET2
was downregulated in the late EPI (Fig. 7c).
The core components of PRC2 complex EZH2, EED and
SUZ12 repress developmental regulators through establishing
trimethylation of lysine 27 in histone 3 (H3K27me3) modiﬁca-
tion36, preventing differentiation of PSCs41. These genes were
expressed at all stages harbouring pluripotent cells in the pig
embryo, while expression of EZH2 and EED was downregulated
in primed pluripotent stages (Fig. 7c), similar to previous
observations in pig epiblasts42 and human PSCs35. Hence, two
populations of pluripotent cells with distinct metabolic and
epigenetic proﬁles exist in the early pig embryo.
Dosage compensation of X-chromosome in pig embryos. To
establish the gender of each cell/embryo, the cumulative level of Y
chromosome gene expression was established (Supplementary
Figure 4a-c). The female-to-male ratio of X-chromosome (XC)
gene expression was higher in females from morula to LB in all
embryonic lineages, suggesting lack of dosage compensation.
However, in Sph EPI, XC gene expression was comparable to that
of autosomes in all embryos, indicating the occurrence of dosage
compensation (Fig. 8a). Analysis of XC gene expression relative to
autosomes at the single-cell level showed uniformity between
male and female cells and conﬁrmed dosage compensation in Sph
EPI (Fig. 8b). A chromosome-wide analysis of female-to-male
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Fig. 4 Progression of pluripotency in the pig embryo: a Principal component analysis (PCA) of the pluripotent lineages (n= 144 cells). b Violin plots of the
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ratio showed a progressive reduction in gene expression along the
whole chromosome with some areas maintaining high ratios of
expression at the spherical stage (Fig. 8c). In agreement with the
dynamics of dosage compensation, XIST expression was detected
in most (81.8%) female cells in the EPI of Sph embryos, with only
sporadic expression of XIST in some male cells (Fig. 8d).
To investigate the mechanism of dosage compensation, we
analysed XC expression at an allelic resolution, quantifying the
expression of single nucleotide variants (SNV) within each cell for
a reference or an alternative allele. As expected, SNVs were not
found in male cells, consistent with the presence of a single XC
(Supplementary Figure 4d). Notably, there was a sharp decline in
the number of biallelically expressed genes in spherical EPI. The
lowest level was detected in female mesoderm cells from E14
embryos, where we detected an inactive XC (Fig. 8e; Supplemen-
tary Figure 4d), which served as a somatic cell control. This result
indicates that dosage compensation at the spherical stage is
attained by inactivation of one XC. To gain a better under-
standing of the X-inactivation process, we analysed the median
expression of biallelically expressed genes. No median reduction
in bi-allelic gene expression was detected en route to dosage
compensation (Sph EPI) (Fig. 8f). The female/male ratio of
biallelically expressed genes was close to 2 in the stages
showing dosage compensation (Fig. 8g). This result suggests that
“dampening” of X-linked gene expression does not precede
dosage compensation. To conﬁrm the inactivation of one X-
chromosome in the epiblast of female spherical embryos, we
analysed Histone H3 lysine 27 trimethylation (H3K27me3),
which accumulates in the inactive X43. A clear single focal
enrichment of H3K27me3 was detected in the nuclei of epiblast
cells in female spherical embryos (Fig. 8h), similar to what is
observed in mesodermal cells (Supplementary Figure 4d). In
contrast, no H3K27me3 foci were found in female LB cells,
consistent with the lack of XCI (Supplementary Figure 4d).
Discussion
We revealed the molecular features of early lineage segregation,
pluripotency and X-inactivation during development of early pig
embryos. Our study provides the basis for comparisons with
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human and mouse development, and for insights in conservation
and divergence of early mammalian development.
Segregation of the ﬁrst three lineages occurs progressively
during pre-implantation development, starting with the TE and
the ICM in early blastocysts. High levels of GATA2 and GATA3
expression detected in early pig TE cells conform to the obser-
vations in early human and Cynomolgus monkey TE2,17. By
contrast, Cdx2 expression is among the earliest markers in the
mouse TE44,45. ICM cells of early pig blastocysts co-express EPI
(NANOG, SOX2) and HYPO (GATA6, PDGFRα, SOX17) mar-
kers, but during the mid-/late blastocyst stage EPI and HYPO
lineages become deﬁnitively segregated, indicating that ICM cells
are bi-potent, able to give rise to mature EPI and HYPO, as
shown in mouse46, human23 and monkey2.
Pathway analysis revealed Jak-Stat signalling enrichment in TE
and ICM of early embryos. The Jak-Stat pathway is an effector of
multiple ligand/receptor interactions including members of the
IL6 family, such as LIF, GCSF and IL6. A previous study showed
that Jak-Stat signalling is essential for TE development in the
pig25. Although there is expression of LIFR in some ICM and TE
of early blastocysts, there is no expression of LIF; either in any of
the cells of the blastocyst, or in the maternal endometrial cells at
this stage47, suggesting that LIF signalling does not have a sig-
niﬁcant role in early pig embryos. Instead, expression of IL6 in
morulae and TE cells of EB, and IL6R and the co-receptor IL6ST
(also known as GP130) in ICM and TE cells, suggests that IL6
likely activates the Jak-Stat pathway by binding to its cognate
receptor. IL-6 supplementation had a modest effect in promoting
TE proliferation, and did not affect ICM development, in contrast
to a previous report on parthenogenetic pig embryos48. However,
IL6−/− gene-edited embryos had a reduced number of TE cells,
but unaffected ICM. Given that blocking Jak-Stat signalling
results in a reduction in TE cells, these experiments show that
Jak-Stat signalling via IL6 has a critical role during pig TE spe-
ciﬁcation. Since Jak-Stat signalling can be stimulated by other
pathways49, such as PI3K-AKT and MAPK, which we showed
can affect the number of ICM cells when blocked, the effects of
Jak inhibition on the ICM may be indirect and not speciﬁc to
IL6 signalling.
Signalling via MEK is important for hypoblast formation in
mouse26 and rabbit27; though this does not seem to be the case in
human23, marmoset13, pig25 and cattle24. Only when using high
concentrations of MEK inhibition we detected a drastic decrease
in SOX17 expression, as reported in cattle28, suggesting that
alternative pathways may be supporting HYPO segregation in
large mammals.
Our study reveals that TGFβ signalling is critical during the
expansion of the epiblast between MB-LB transition, but not in
EPI/HYPO segregation, consistent with previous reports24,25.
TGFβ signalling is needed for hESC self-renewal50, and inhibition
of this pathway affects NANOG expression in human and mar-
moset blastocysts11,13. Similarly, NANOG expression in pig
embryos is also affected by inhibition with SB431542. Further-
more, we show high expression of TGFβ components in EPI cells
compared to ICM, suggesting that this pathway becomes active in
advanced embryos, pointing to a critical role of TGFβ during the
epiblast expansion.
Analysis of embryonic cells revealed an expression proﬁle with
genes characteristic of naive pluripotency in morula and ICM
cells (made of ~10–15 cells) of EB (E~5–6), and of primed
Table 4 Gene ontology and KEGG pathways determined by pairwise comparisons of pluripotent cells of the pig embryo
Lineage GO terms KEGG pathways
M vs. EB ICM
M Positive regulation of JNK cascade (9.958e−03)
Mitochondrial outer membrane permeabilization (1.83e−02)
Positive regulation of Wnt signalling pathway, planar cell polarity pathway
(1.19e−02)
Notch signalling pathway (1.04e−02)
Tight junction (5.67e−11)
Hippo signalling pathway (1.11e−06)
Wnt signalling pathway (1.11e−05)
Notch signalling pathway (2.79e−02)
Jak-STAT signalling pathway (3.79e−02)
EB ICM Endodermal cell differentiation (1.58e−03)
Regulation of ERK1 and ERK2 cascade (1.01e−02)
Interleukin-6-mediated signalling pathway (4.04e−03)
Positive regulation of stem cell population maintenance (6.78e−03)
PI3K-Akt signalling pathway (1.51e−08)
Signalling pathways regulating pluripotency of stem cells
(3.07e−05)
MAPK signalling pathway (3.62e−02)
EB ICM vs. LB EPI
EB ICM Positive regulation of interleukin-6 production (2.51e−03)
Interleukin-6-mediated signalling pathway (3.16e−03)
Hydrogen ion transmembrane transport (4.00e−03)
Tricarboxylic acid cycle (8.77e−03)
Mitochondrial electron transport, cytochrome c to oxygen (1.63e−02)
Signalling pathways regulating pluripotency of stem cells
(4.45e−06)
PPAR signalling pathway (6.62e−05)
PI3K-Akt signalling pathway (1.54e−04)
Jak-STAT signalling pathway (2.30e−02)
LB EPI Regulation of ERK1 and ERK2 cascade (6.76e−04)
Response to hypoxia (3.06e−03)
Positive regulation of MAP kinase activity (5.37e−03)
DNA methylation (1.32e−02)
C-5 methylation of cytosine (1.94e−02)
Transforming growth factor beta receptor signalling pathway (2.25e−02)
Gap junction (8.74e−04)
AMPK signalling pathway (4.62e−03)
Axon guidance (2.21e−02)
TGF-beta signalling pathway (3.60e−02)
LB EPI vs. Sph EPI
LB EPI Regulation of DNA methylation (2.01e−03)
Chromatin organisation (2.33e−03)
Positive regulation of stem cell proliferation (4.54e−03)
Histone H4 deacetylation (2.20e−02)
Sph EPI Axon development (2.36e−02)
Response to hypoxia (6.50e−03)
Negative regulation of apoptotic process (2.94e−03)
Cellular response to oxidative stress (1.22e−02)
Focal adhesion (3.88e−04)
ECM–receptor interaction (1.59e−02)
Signiﬁcance values in brackets
M morula, EB early blastocyst, LB late blastocyst, Sph spherical embryo, ICM inner cell mass, EPI epiblast
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pluripotency in the EPI of LB (~E7/8) and Sph (~E10/11)
embryos, which coincides with an expansion of the epiblast from
~25 cells in LB to more than ~180 in Sph. Given that cells with
naive pluripotent gene expression are only transiently present
(~1 day) and instead cells with primed pluripotent expression
grow for a protracted period (~3–4 days), the latter could be
captured as self-renewing cells in vitro. Indeed, pig pluripotent
cell lines with primed characteristics have been reported21,51–53,
but not of those with characteristics of naive pluripotency; the
latter may require different culture conditions capable of stimu-
lating their proliferation. Differences in naive pluripotency
properties between mouse and other mammals may underlie the
difﬁculties in establishing equivalent cells from the latter in vitro.
Pig naive pluripotency markers include KLF4/5/17, TBX3 and
TCFPL21, and are consistent with those reported in human11 and
monkeys2,13, which differ from mouse naive pluripotency, which
is characterised by the expression of Klf2, Prdm14 and Bmp4.
These genes participate in regulating gene expression, epigenetic
reprogramming, and cellular signalling, respectively, which
highlight potential functional differences in naiveté between mice
and larger mammals.
The transition from naive to primed pluripotent gene expres-
sion in the pig embryo is accompanied by a change in expression
of genes indicative of a metabolic shift from OXPHOS towards
glycolysis. This is supported by an increase in L-lactate production
in late pig blastocysts compared to morulae54. The metabolic
switch likely provides critical metabolites to promote epiblast
expansion, as well as epigenetic remodelling through epigenetic
modiﬁcations of DNA and histones, a crucial step in preparation
for the next major developmental event that is the onset of
gastrulation.
Diverse mechanisms exist in mammals for dosage compensa-
tion with respect to the XC in females55. In mice, imprinted XCI
results in inactivation of the paternal XC in early cleaving
embryos, followed by reactivation in the ICM of blastocyst
(excluding the extraembryonic tissues), and then random XCI in
the epiblast56. In contrast, there is no imprinted XCI in human
and rabbit embryos. Indeed, the expression of XIST from both X
chromosomes in blastocysts suggests alternative mechanisms of
dosage compensation56. The “dampening” of X-linked genes
from both parental chromosomes as a possible mechanism12
warrants further studies57. Another report indicated incomplete
dosage compensation of a subset of X-linked genes in pig blas-
tocysts15,58. Notably, our observations however show XCI in the
mature EPI, as demonstrated by the reduction in the number of
biallelically expressed X-linked genes, coupled with the appear-
ance of the H3K27me3 mark on the inactive XC.
Our study at the resolution of single cells allows comparisons
between species to identify developmental equivalence. Com-
parison of mouse and pig pluripotent matched stages showed
broad developmental alignment, although the developmental time
in mice is three times shorter compared to pigs (2 days vs.
6 days). Yet the overall principles of the emergence and estab-
lishment of pluripotency are conserved between these species
(Fig. 9a). Developmental progression showed broad equivalence
between morula to epiblast transitions in humans and pigs.
Importantly, human embryonic stem cells (hESC) with naive and
primed characteristics grouped closely to human late ICM and
EPI cells, respectively, and these also aligned with pig EPI cells
(Fig. 9b). Our observations may be relevant for understanding
events during early human development, as well as for attempts
to study speciﬁcation of hESCs in chimeras with pig embryos as
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hosts, following their introduction into blastocysts. Hitherto, the
reported efﬁciency of these experiments is very low59, perhaps
because the hESCs were not in-sync with the host pig blastocyts.
Developmental synchrony between donor and host is important
for efﬁcient chimerism60. We propose that the introduction of
primed state hESCs into late pig blastocysts may be a more
favourable environment for homing of hESC, and their sub-
sequent development in chimeras.
In conclusion, this comprehensive analysis depicts molecular
landmarks of pig embryogenesis that provides new insights into
embryos with protracted epiblast development (Fig. 9c). Fur-
thermore, the shared features of lineage segregation and plur-
ipotency between humans and pigs revealed here will help
accelerate research into novel approaches in regenerative medi-
cine, such as the development of interspecies chimeras.
Methods
Porcine embryo collection. All of the procedures involving animals have been
approved by the School of Biosciences Ethics Review Committee, The University of
Nottingham. Embryos at each stage were retrieved from multiple crossbred Large
White and Landrace sows (2–3 years old) between days 4 and 11 after artiﬁcial
insemination. Embryos were ﬂushed from the uterine horns with 30–40 ml warm
PBS (supplemented with 1% FCS), washed and transported to the laboratory in
N2B27 supplemented with 25 mM HEPES in a portable incubator at 38.5 °C.
Oocyte collection and IVM. Oocytes were aspirated from antral follicles (3–6 mm
diameter) of ovaries from pre-pubertal gilt ovaries collected at a local slaughter-
house. Cumulus-oocyte complexes (COCs) with several layers of unexpanded
cumulus cells and evenly dark cytoplasm were selected for maturation. COCs were
washed in TCM-199 containing 2 mgml−1 BSA, and placed in individual wells
containing 500 μl of maturation medium composed of TCM-199 containing 3.05
mM glucose, 0.91 mM sodium pyruvate, 0.57 mM cysteine, 0.1% w/v polyvinyl
alcohol, 10 ng ml−1 EGF, 20 ng ml−1 LIF, 40 ng ml−1 FGF2, 10 ng ml−1 FSH and
0.5 µg ml−1 LH for 42–44 h at 38.5 °C in 5% CO2 air61.
At the end of the maturation period, the cumulus cells adhering to the oocyte
were removed by pipetting for 2 min in 1 mgml−1 hyaluronidase. Matured oocytes
were identiﬁed by the presence of a polar body.
sgRNA design and in vitro transcription. The online software MIT CRISPR
Design Tool (http://crispr.mit.edu) was used to design sgRNAs targeting IL6 gene.
The CRISPR/Cas9 target sequences (20 bp target and 3 bp PAM sequence
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(underlined)) used in this study are shown as follow: gRNA1: ATCTTCTTCCAG
GCGTCCCGGGG; gRNA2: TCATTGCAGAGATTTTGCCGAGG. The sgRNAs
were produced using Geneart Precision gRNA Synthesis Kit (Thermo Fisher Sci-
entiﬁc) and speciﬁc primers (Supplementary Information). sgRNAs were tested
individually and in combination in parthenogenetic embryos.
Microinjection of sgRNAs and Cas9 protein. Matured oocytes were washed with
TCM-199 containing 25 mM Hepes (Gibco), transferred into a 30 μl drop of TCM-
199-Hepes medium and placed on an inverted microscope ﬁtted with micro-
manipulators to microinject Cas9 ribonucleoprotein complex mixture. Brieﬂy, 3 μl
of 250 ng μl−1 Cas9 protein (ToolGen Inc, South Korea) was mixed with 3 μl of
250 ng μl−1 sgRNA mixture (gRNA1 and gRNA2) and incubated for 10 min at 37 °
C. The resulting Cas9 ribonucleoprotein complex mixture was diluted to a ﬁnal
concentration of 25 ng μl−1 for microinjection. Cas9 ribonucleoprotein complex
was loaded to a spike-end micropipette of 5–7 μm internal diameter (ID) con-
nected to a manual hydraulic air microinjector. Zygotes were secured by a holding
pipette and the pipette was advanced into the zygote, and cytoplasm was aspirated
until the plasma membrane was broken to then deliver the Cas9 ribonucleoprotein
complex into the cytoplasm. Groups of 20 zygotes were manipulated simulta-
neously. After microinjection, the oocytes were parthenogenetically activated.
Parthenogenetic activation and embryo culture. Microinjected oocytes were
electrically activated with two pulses of 120 Vmm−1 for 40 μs, delivered by an
Eppendorf Multiporator using a 0.5 mm chamber containing 0.3 M mannitol, 0.05
mM CaCl2, 0.1 mM MgSO4 and 0.1% bovine serum albumin (BSA). After washing
with PZM5, the oocytes were chemically activated with 2 mM DMAP and 5 μg ml
−1 cytochalasin B in PZM562 for 5 h to generate diploid parthenogenetic embryos.
After activation, porcine zygotes were cultured in 500 μl of PZM5 containing 0.3%
BSA for 5 days. After 5 days of culture, embryos were cultured in
N2B27 supplemented with 0.3% BSA25 at 38.5 °C in a humidiﬁed atmosphere of
5% CO2, 5% O2 and 90% N2. Day 7 blastocysts were ﬁxed in 2% paraformaldehyde
(PFA) for 10 min at RT after removing zona pellucidae with Tyrode’s acid. After
immunostaining embryos were recovered for genotyping.
Embryo genotyping after gene editing. Each embryo was placed in 2.5 µl
Accutase, and 5 µl Alkaline Lysis buffer (50 mM NaOH, 0.4 mM EDTA) was
added. After 20 min incubation at 99 °C, the lysis reaction was neutralised with 5 µl
40 mM Tris–HCl (pH 5). DNA was ampliﬁed in two rounds of 40 cycles of PCRs
using KAPA HiFi HotStart ReadyMix (Roche) for the ﬁrst round and Sigma
ReadyMix with 1:10 of the ﬁrst PCR product for the second round and speciﬁc
primers (Supplementary Information). Agarose gel electrophoresis was followed by
gel extraction of the bands and Sanger Sequencing. The sequences were aligned to
the Wildtype sequence using the MUSCLE alignment tool (EMBL-EBI). For mixed
pherograms, the TIDE webtool was used63.
Isolation of single cells for single-cell cDNA preparation. Zona pellucidae were
removed using acidic Tyrode’s solution (Sigma) in morulae and early blastocysts,
and then embryos were dissociated. Late blastocysts were subjected to immuno-
surgery to remove the trophectoderm based on previously described procedures64.
Brieﬂy, embryos were incubated for 30 min in a 1:5 dilution of anti-pig serum
(Sigma) in N2B27 medium, washed and incubated for 30 min in 1:5 dilution of
complement (Sigma). Embryos were transferred to N2B27 for a few minutes for
efﬁcient cell lysis, and then embryonic disks were isolated from the trophectoderm
by repeated aspiration with a pulled glass capillary. In spherical embryos, epiblast
and hypoblast were manually isolated. Trophectoderm cells were not collected
from late blastocysts and spherical embryos.
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Single-cell dissociation was performed by incubation in TrypLE Express
(GIBCO) for 5 min at 37 °C and repeated pipetting using very thin pulled
capillaries. Individual cells were subsequently transferred to DMEM+20% FCS to
block TrypLE Express and washed in a small drop of PBS-PVP. Single cells were
manually collected into PCR tubes to prepare single-cell cDNA libraries following
the Smart-seq2 protocol65.
Brieﬂy, single cells were lysed by incubation at 72 °C for 3 min in PCR tubes
containing 4 μl of cell lysis buffer, oligo-dT primer and dNTP mix. Reverse
transcription and PCR pre-ampliﬁcation were carried out with SuperScript II
(Invitrogen) and KAPA HiFi HotStart ReadyMix (KAPA Biosystems) respectively
according to Picelli et al. protocol. PCR products were puriﬁed using Ampure XP
beads (Beckman Coulter), and library size distribution was checked on Agilent
dsDNA High Sensitivity DNA chips on an Agilent 2100 Bioanalyzer (Agilent
Technologies). Concentration was quantiﬁed using Qubit Quant-iT dsDNA High-
Sensitivity Assay Kit (Invitrogen). Samples with more than 0.2 ng µl−1, free of short
fragments (<500 bp) and with a peak at around 1.5–2 kb were selected for library
preparation with Nextera XT DNA Library Preparation Kit (Illumina).
Tagmentation reaction and further PCR ampliﬁcation for 12 cycles were carried
out, and PCR products were again puriﬁed using Ampure XP beads. Quality of the
ﬁnal cDNA library was analysed on an Agilent high-sensitivity DNA chip. Final
cDNA libraries had an average size of 700–800 bp and were quantiﬁed using
NEBNext Library Quant Kit for Illumina (New England BioLabs) following the
manufacturer instructions. Finally, libraries were pooled in groups of 50 with a 2
nM ﬁnal concentration, and DNA sequencing was performed on a HiSeq 2500
Sequencing System (Illumina).
Single-cell RNA-Seq data. Raw PE reads were trimmed against adaptor sequences
by scythe (v0.981), and quality-trimmed by sickle (v1.33) using default settings.
Trimmed reads were directionally aligned to the pig genome (Sus scrofa v10.2) by
hisat2 (v2.1.0) with -know-splicestie-inﬁle setting to increase mapping accuracy of
splicing reads. Uniquely and correctly mapped reads were extracted for the
downstream analysis. htseq-count was used to count the number of reads aligned to
each gene (Sus scrofa v10.2 ensembl annotation build 87). Gene expression level
was calculated and normalised by Transcripts Per Kilobase Million (TPM).
Low quality cells were ﬁltered out from the dataset to reduce the downstream
analysis noise. First, the total number of reads mapped to gene transcripts was
calculated for each cell, and those with less than 1 million were removed. Second,
the proportion of reads aligned to mitochondrial genes was estimated, as a high
proportion suggests poor quality cells66. The proportion cut-off was set at 0.5. Only
cells of proportions below 0.5 were kept for the next analysis. Third, 4 outlier cells
were identiﬁed by t-SNE dimensionality reduction. A total of 13,815 out of 22,824
annotated genes were identiﬁed in at least 3 cells with TPM > 1.
Lineage segregation of cells. The R package “scater” was applied to normalise
read counts of genes for each good quality cell with acceptable sequencing cov-
erage. A non-linear approach, t-stochastic neighbour embedding (t-SNE), was used
to identify the relations between cells using normalised read counts. Unsupervised
hierarchical clustering using all expressed genes as input was conducted on all
ﬁltered cells by normalised read counts in log2 scale. The distance method was
euclidean, and the cluster method was ward.D2.
Lineage differential expression analysis. Pairwise comparisons of single-cell
differential expressions were performed by SCDE using normalised read counts
among four embryo stages. Two-tailed adjusted p-value were calculated using cZ
scores from Benjamini–Hochberg multiple testing corrections, and followed a
normal distribution. Signiﬁcantly expressed genes were selected with a p-value
<0.05 as the threshold. A heat map of differentially expressed genes (DEGs) was
created with a log2 scale of normalised expression. Euclidean distance and default
hclust were applied to determine the relationships between cells and between genes.
Gene Ontology (GO) gene set enrichment analysis with DEGs utilised goseq for
each pairwise comparison, also with upregulated DEGs and downregulated DEGs
separately. GO term annotation was retrieved from the Ensembl database (Sus
scrofa v10.2 ensembl annotation version 87). Enrichment analysis of biological
pathway was performed with DEGs by gage. Ensembl gene IDs of DEGs were
mapped to NCBI gene IDs for KEGG pathway prior to enrichment analysis.
Lineage subpopulation analysis. Cell lineages were investigated for subpopula-
tion analysis. An outlier EB ICM cell was excluded by PCA based on log2 TPM
values of all expressed genes. LB and Sph cells were grouped together for PCA. Two
contrasting methods of PCA were applied; one using all expressed genes, and the
other based on the highly variable genes (HVGs) only. We used decomposeVar to
detect HVGs with a loess regression ﬁt model. FDR ≤ 0.05 was applied as a sig-
niﬁcance cut-off.
Inference of embryonic sex. Expressions of all the Y chromosomal genes were
summed up to determine the sex of each cell. A cell with the total chromosome Y
TPMs ≥ 100 ðP
chrY
gene
TPMÞ was regarded as a male cell, while P
chrY
gene
TPM<100 regarded
as a female cell.
Chromosome X dosage compensation analysis. Genes of chromosome X and
three autosomes (chr1, chr2, chr3) were extracted, and the geometric mean TPM of
chromosomal expressed genes was calculated for each cell separately. Then the
overall geometric mean TPM was obtained for each developmental stage by
embryo sex, as well as the total TPM. Each TPM value was incremental by one
(TPM+ 1) for the calculation of geometric mean TPM. Only shared expressed
genes between female and male cells were taken into account in the calculation of
female/male expression ratio for each chromosome. For each cell, the ratio of chrX/
auto was inferred by total TPMs, and grouped by embryo sex. Median Female/Male
expression ratio was estimated for each stage across the whole chromosome X with
1 Mb window.
Analyses of allelic expression. Trimmed reads were aligned to chromosome X of
the pig genome (Sus scrofa v10.2) by hisat2. Duplicated reads were marked by
picard (v2.12.1). GATK (v3.8) was used to retrieve allelic read counts for SNVs
annotated in dbSNP (build 147). Only validated SNVs (dbSNP ﬂag VLD) were
extracted for downstream analysis. SnpEff (v4.3) was applied to annotate called
SNVs with Sus scrofa v10.2 ensembl annotation (build 87). Low coverage SNVs (<3
reads) were excluded from the analysis, and we only kept SNVs that occurred at
least in two different cells for each stage. The expressions of mono-/bi-allelic genes
were estimated based on SNVs in each female cell of each stage.
Gene clustering by expression proﬁle. Self-organising map (SOM) were used to
discover potential structural patterns in highly dimensional and complex datasets
by creating 2-dimensional representations. The SOM algorithm was applied to our
gene expression proﬁle. The geometric mean TPM of each gene was calculated
within each stage. In order to ﬁt the SOM model, the lower TPMs (<1) were
replaced by 1, and the extreme higher TPMs were replaced by 10,000. Similarly,
genes of highly similar expression proﬁles within stages were excluded
ðmaxðTPMÞminðTPMÞ  1 ormax TPMð Þ min TPMð Þ  0Þ. The ﬁltered TPMs were then
normalised by SOM (μ= 0, σ= 1). In total, 25 clusters were created.
Comparison of pig, mouse and human datasets. In total, 144 pig cells (our
study), 83 mouse8 cells and 152 human cells retrieved from Petropoulos et al.12 and
re-classiﬁed according to Stirparo et al.7 were included in the comparative analysis.
PSC lines cultured under conventional or naive conditions were used for analysis as
described by Stirparo et al.7 Pig orthologous genes (15,171) were retrieved against
human genes from Ensembl database (compara build 87). Expression values were
normalised by TPM for PCA analysis. Linear regressions were calculated separately
for PC2 and PC3, which contributed to pig and human developmental genes,
respectively.
Embryo treatments with inhibitors, growth factors and IF. Embryos were
incubated in PZM5 culture medium up to morula stage and in N2B27 medium
supplemented with 0.3% fatty acid free BSA from compact morula onwards, in a
humidiﬁed atmosphere at 39 °C and 5% O2. The embryos were treated with the
following inhibitors and cytokines: 10 µM PD0325901 (Tocris), 20 µM SB431542
(Tocris), 10 µM LY294002 (Selleckem), 2.5 µM IWP2 (Sigma), 10 µM AZD1480
(Sigma), 10 ng ml−1 porcine IL-6 (R&D), 10 ng ml−1 TGFβ1 (Peprotech). All
inhibitor treatments were performed for 48 h during the indicated time points;
from pre-morula (PM) to early blastocyst (EB), from morula (M) to mid blastocyst
(MB) and from mid blastocyst to late blastocyst (LB). For the growth factors
embryos were cultured from the morula to the late blastocyst stage (72 h). Inhi-
bitors were dissolved in DMSO and control embryos were treated with DMSO
accordingly.
After the treatments, embryos before hatching stage were treated with Tyrode’s
acid to remove zona pellucidae. Then, embryos were ﬁxed in 4% paraformaldehyde
(PFA) for 15 min at room temperature (RT), washed in PBS-1% BSA,
permeabilized in 0.2% Triton X-100 for 15 min at RT and blocked in blocking
solution (PBS with 0.1% BSA, 0.2% Tween and 10% Donkey serum) for 1 h at RT.
Embryos were incubated overnight at 4 °C with the primary antibodies: NANOG
(Peprotech, 500-P236, 1:200 dilution in blocking solution), SOX17 (R&D, AF1924,
1:200), SOX2 (Santa Cruz, sc-17320, 1:300), CD244 (Proteintech, 16677-1, 1:100),
H3K27me3 (Active Motif, 39157, 1:500). After 4 washes in PBS-1% BSA, embryos
were incubated in the appropriate secondary antibodies: Donkey anti-rabbit IgG
Alexa 488 (Invitrogen, R37118, 1:500), Donkey anti-goat IgG Cy3 (Jackson, 705-
165-003, 1:500) for 45 min at RT, followed by four washes in PBS-1% BSA. Finally,
embryos were mounted in Fluoroshield with DAPI (Sigma).
Statistical analysis. To evaluate the statistical differences in cell count numbers
from individual embryos, probability (p) values were calculated using two-sided
Mann–Whitney test between each treatment and the control. Percentages of
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contribution of NANOG+ only, SOX17+ only and co-expressing cells were eval-
uated by two-way ANOVA (Dunnett’s multiple comparisons test). Differences
were considered signiﬁcant when p < 0.05.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data generated or analysed during this study are included in this published
article and its supplementary information ﬁles. The source data underlying Figs. 1a,
2a–d, 3c-f, 6d, h and 7c and Supplementary Figures 1a and 5d are provided as a
Source Data ﬁle. The scRNA-Seq datasets generated during this study are available
under GEO accession number: GSE112380 .
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